KLK3 and benign prostatic hyperplasia: Figure 2B showed that the intensity of immunoreaction to PSA decreased from BPH samples to prostate adenocarcinoma (34.39 ± 0.53 and 17.85 ± 1.21, respectively) (p < 0.0001).